We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$71.7B
AUM Growth
+$2.34B
Cap. Flow
+$1.49B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.97%
Holding
3,809
New
183
Increased
1,708
Reduced
1,572
Closed
206

Sector Composition

Rank Sector Weight
1 Technology 10.59%
2 Financials 9.51%
3 Healthcare 8.04%
4 Industrials 6.62%
5 Communication Services 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INST
3051
DELISTED
Instructure, Inc.
INST
$272K ﹤0.01%
7,011
-5,208
-43% -$212K
PCM
3052
PCM Fund
PCM
$70M
$271K ﹤0.01%
24,362
+899
+4% +$10K
IWX icon
3053
iShares Russell Top 200 Value ETF
IWX
$4.05B
$270K ﹤0.01%
4,924
FIZZ icon
3054
National Beverage
FIZZ
$2.91B
$269K ﹤0.01%
12,124
-436
-3% -$9.41K
NAV
3055
DELISTED
Navistar International
NAV
$269K ﹤0.01%
9,585
BWX icon
3056
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.31B
$267K ﹤0.01%
9,318
-1,729
-16% -$49.9K
IOVA icon
3057
Iovance Biotherapeutics
IOVA
$2.9B
$264K ﹤0.01%
14,512
-4,281
-23% -$94.7K
BHF icon
3058
Brighthouse Financial
BHF
$3.46B
$263K ﹤0.01%
6,502
-1,747
-21% -$65.1K
CDE icon
3059
Coeur Mining
CDE
$18.7B
$263K ﹤0.01%
54,640
+15,490
+40% +$76.8K
MOG.A icon
3060
Moog Inc Class A
MOG.A
$13B
$262K ﹤0.01%
3,226
+209
+7% +$17.8K
ZWS icon
3061
Zurn Elkay Water Solutions
ZWS
$8.47B
$262K ﹤0.01%
20,079
-3,131
-13% -$41.9K
MWA icon
3062
Mueller Water Products
MWA
$4.07B
$261K ﹤0.01%
23,265
-1,280
-5% -$13.1K
VSMV icon
3063
VictoryShares US Multi-Factor Minimum Volatility ETF
VSMV
$158M
$261K ﹤0.01%
+8,157
New +$256K
AVNS
3064
DELISTED
Avanos Medical
AVNS
$260K ﹤0.01%
6,952
+829
+14% +$31.6K
JCI icon
3065
CALL
Johnson Controls International
JCI
$91.3B
$260K ﹤0.01%
49,500
-200
-0.4% -$8.47K
TFSL icon
3066
TFS Financial
TFSL
$4.83B
$260K ﹤0.01%
14,450
-3,300
-19% -$59.2K
MCBC
3067
DELISTED
Macatawa Bank Corp
MCBC
$260K ﹤0.01%
25,010
MOBL
3068
DELISTED
MobileIron, Inc.
MOBL
$260K ﹤0.01%
39,780
+28,700
+259% +$196K
CEO
3069
DELISTED
CNOOC Limited
CEO
$260K ﹤0.01%
1,706
+466
+38% +$73.3K
PCRX icon
3070
Pacira BioSciences
PCRX
$974M
$259K ﹤0.01%
6,813
-1,375
-17% -$54.9K
HUBG icon
3071
HUB Group
HUBG
$2.9B
$258K ﹤0.01%
11,100
ESBA icon
3072
Empire State Realty Series ES
ESBA
$1.23B
$257K ﹤0.01%
18,090
NMFC icon
3073
New Mountain Finance
NMFC
$726M
$256K ﹤0.01%
18,747
+711
+4% +$9.69K
GWX icon
3074
State Street SPDR S&P International Small Cap ETF
GWX
$914M
$255K ﹤0.01%
8,686
+303
+4% +$8.87K
ARA
3075
DELISTED
American Renal Associates Holdings, Inc
ARA
$255K ﹤0.01%
40,294
+18,000
+81% +$134K

Similar funds

Raymond James & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Raymond James & Associates held 3,809 positions worth $71.7B, up 3.4% from $69.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Raymond James & Associates's Q3 2019 filing shows 183 new, 1,708 increased, 1,572 reduced and 206 closed positions. Its largest new stake was Change Healthcare Inc. Common Stock: 949,970 shares worth $11.5M. The largest sale was Microchip Technology, an estimated $155M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2019 buy was Change Healthcare Inc. Common Stock: 949,970 shares worth $11.5M.
  • Raymond James & Associates added most to Comcast in Q3 2019, an estimated $203M increase.
  • Raymond James & Associates's biggest Q3 2019 reduction was Microchip Technology, cutting an estimated $155M.
  • Raymond James & Associates fully exited Anadarko Petroleum in Q3 2019, selling an estimated $89.3M.
  • Raymond James & Associates's ten largest holdings make up 22% of its $71.7B portfolio in Q3 2019.
  • Raymond James & Associates opened 183 new positions and closed 206 in Q3 2019.
  • Raymond James & Associates's portfolio value rose 3.4% quarter-over-quarter to $71.7B.

Based on Raymond James & Associates's 13F filing for Q3 2019, filed 7 Nov 2019.